PKPatrick C. Kinnunen

Patrick C. Kinnunen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Patrick C. Kinnunen has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Automation and machine learning drive rapid optimization of isoprenol production in Pseudomonas putida

    by David N. Carruthers, Patrick C. Kinnunen, Yuerong Li, Yan Chen, Jennifer W. Gin, Ian S. Yunus, William R. Galliard, Stephen Tan, Tijana Radivojevic, Paul D. Adams, et al.

    Advances in genome engineering have improved our ability to perturb microbial metabolic networks, yet bioproduction campaigns often struggle with parsing complex metabolic datasets to efficiently enhance product titers. We address this challenge by coupling laboratory automation with machine learning to systematically optimize the production of isoprenol, a sustainable aviation fuel precursor, in Pseudomonas putida. The simultaneous downregulation through CRISPR interference of combinations of up to four gene targets, guided by machine learning, permitted us to increase isoprenol titer 5-fold in six consecutive design-build-test-learn cycles. Moreover, machine learning enabled us to swiftly explore a vast experimental design space of 800,000 possible combinations by strategically recommending approximately 400 priority constructs. High-throughput proteomics allowed us to validate CRISPRi downregulation and identify biological mechanisms driving production increases. Our work demonstrates that ML-driven automated design-build-test-learn cycles, when combined with rigorous data validation, can rapidly enhance titers without specific biological knowledge, suggesting that it can be applied to any host, product, or pathway.


  • Open Access

    Inference of weak-form partial differential equations describing migration and proliferation mechanisms in wound healing experiments on cancer cells

    by Siddhartha Srivastava, Patrick C. Kinnunen, Zhenlin Wang, Kenneth K.Y. Ho, Brock A. Humphries, Siyi Chen, Jennifer J. Linderman, Gary D. Luker, Kathryn E. Luker, Krishna Garikipati

    Cancer metastasis, which requires migration of cancer cells away from the primary tumor, is responsible for approximately 65% percent of cancer-related deaths. Therefore, targeting signaling pathways that drive cancer cell migration or proliferation is a common therapeutic approach. Cell migration is commonly studied using experimental approaches which track cells or cell monolayers as they evolve over time. Computational modeling can then be used to fit partial differential equation (PDE) models to the data, providing mechanistic insights underlying the observed cell motion, including the contribution of various cellular behaviors such as random motion, directed motion, and cell division. A popular experimental technique, the scratch assay, measures the migration and proliferation-driven cell closure of a scratch in a confluent cell monolayer. However, these assays do not disambiguate between different drivers of scratch closure (for instance between cell proliferation and migration to open space). To improve analysis of this technique, we combine scratch assays, video microscopy, and PDE inference to gain quantitative insight to mechanisms of cell migration and proliferation. We capture the evolution of cell density fields over time using live-cell microscopy and automated image processing. Our PDE inference methods involve the use of weak form-based system identification techniques for cell density dynamics modeled with advection-diffusion-reaction systems. We then compare our method with recent modeling work, finding that our model discovery tool automatically identifies similar models including reaction and diffusion terms from a larger set of bases. We demonstrate the application of this framework on 2-dimensional scratch assays subject to the inhibiting effect of trametinib on wound closure and characterize the results in the context of the quantified uncertainty in our inference approach. Our integrated experimental and computational pipeline can be used to rapidly identify and refine models of cell migration in a variety of contexts, enabling the quantitative measurement of the effect of drugs and other perturbations on cell migration and proliferation with uncertainty accounted for.


  • Open Access

    Automation and machine learning drive rapid optimization of isoprenol production in Pseudomonas putida

    by David N. Carruthers, Patrick C. Kinnunen, Yuerong Li, Yan Chen, Jennifer W. Gin, Ian S. Yunus, William R. Galliard, Stephen Tan, Paul D. Adams, Anup K. Singh, et al.

    Advances in genome engineering have improved our ability to perturb microbial metabolic networks, yet bioproduction campaigns often struggle with parsing complex metabolic datasets to efficiently enhance product titers. We address this challenge by coupling laboratory automation with machine learning to systematically optimize the production of isoprenol, a sustainable aviation fuel (SAF) precursor, in Pseudomonas putida . The simultaneous downregulation through CRISPR interference of combinations of up to four gene targets, guided by machine learning (ML), permitted us to increase isoprenol titer 5-fold in six consecutive DBTL cycles. Moreover, ML enabled us to swiftly explore a vast experimental design space of 800,000 possible combinations by strategically recommending approximately 400 priority constructs. High-throughput proteomics allowed us to validate CRISPRi downregulation and identify biological mechanisms driving production increases. Our work demonstrates that ML-driven automated DBTL cycles can rapidly enhance titers without specific biological knowledge, suggesting that it can be applied to any host, product, or pathway. *David N. Carruthers & Patrick C. Kinnunen contributed equally.


  • Open Access

    Prediction of metabolic dynamics through deep learning and high-throughput multiomics data

    by Jose Manuel Marti, Patrick C. Kinnunen, Mark Held, Azadeh Alikhani, Andrew Conley, Yan Chen, Tijana Radivojevic, Jennifer W. Gin, Apostolos Zournas, Rebecca M. Lennen, et al.

    Synthetic biology’s remarkable potential to tackle important societal problems is held back by our inability to predictably engineer biological systems. Here, we collected one of the largest public multiomics synthetic biology datasets generated to date, and used it to train a novel deep learning algorithm able to predict product and metabolic dynamics with great accuracy, starting to approach the predictive capabilities found in physics and chemistry. We were able to predict production time series with 90-99% accuracy, and final production with 96% accuracy. Further, we were able to produce good predictions for a majority of extracellular metabolites, and twenty different intracellular metabolites. These predictions were provided for a target of industrial relevance: a non-model yeast ( Pichia kudriavzevii ) engineered to produce large amounts of malonic acid, a desirable biomanufacturing target. This approach is generally applicable to any host, pathway, and product because all required knowledge is inferred from experimental data.

  • Open Access

    Author Correction: Machine learning-led semi-automated medium optimization reveals salt as key for flaviolin production in Pseudomonas putida

    by Apostolos Zournas, Matthew R. Incha, Tijana Radivojevic, Vincent Blay, Jose Manuel Martí, Zak Costello, Matthias Schmidt, Tan Chung, Mitchell G. Thompson, Allison Pearson, et al.

  • Top Cited Papers
    Open Access

    Machine learning-led semi-automated medium optimization reveals salt as key for flaviolin production in Pseudomonas putida

    by Apostolos Zournas, Matthew R. Incha, Tijana Radivojevic, Vincent Blay, Jose Manuel Martí, Zak Costello, Matthias Schmidt, Tan Chung, Mitchell G. Thompson, Allison Pearson, et al.

    Although synthetic biology can produce valuable chemicals in a renewable manner, its progress is still hindered by a lack of predictive capabilities. Media optimization is a critical, and often overlooked, process which is essential to obtain the titers, rates and yields needed for commercial viability. Here, we present a molecule- and host-agnostic active learning process for media optimization that is enabled by a fast and highly repeatable semi-automated pipeline. Its application yielded 60% and 70% increases in titer, and 350% increase in process yield in three different campaigns for flaviolin production in Pseudomonas putida KT2440. Explainable Artificial Intelligence techniques pinpointed that, surprisingly, common salt (NaCl) is the most important component influencing production. The optimal salt concentration is very high, comparable to seawater and close to the limits that P. putida can tolerate. The availability of fast Design-Build-Test-Learn (DBTL) cycles allowed us to show that performance improvements for active learning are rarely monotonous. This work illustrates how machine learning and automation can change the paradigm of current synthetic biology research to make it more effective and informative, and suggests a cost-effective and underexploited strategy to facilitate the high titers, rates and yields essential for commercial viability.


  • Open Access

    Guide RNA structure design enables combinatorial CRISPRa programs for biosynthetic profiling

    by Jason Fontana, David Sparkman-Yager, Ian Faulkner, Ryan Cardiff, Cholpisit Kiattisewee, Aria Walls, Tommy G. Primo, Patrick C. Kinnunen, Hector Garcia Martin, Jesse G. Zalatan, et al.

    Engineering metabolism to efficiently produce chemicals from multi-step pathways requires optimizing multi-gene expression programs to achieve enzyme balance. CRISPR-Cas transcriptional control systems are emerging as important tools for programming multi-gene expression, but poor predictability of guide RNA folding can disrupt expression control. Here, we correlate efficacy of modified guide RNAs (scRNAs) for CRISPR activation (CRISPRa) in E. coli with a computational kinetic parameter describing scRNA folding rate into the active structure (rS = 0.8). This parameter also enables forward design of scRNAs, allowing us to design a system of three synthetic CRISPRa promoters that can orthogonally activate (>35-fold) expression of chosen outputs. Through combinatorial activation tuning, we profile a three-dimensional design space expressing two different biosynthetic pathways, demonstrating variable production of pteridine and human milk oligosaccharide products. This RNA design approach aids combinatorial optimization of metabolic pathways and may accelerate routine design of effective multi-gene regulation programs in bacterial hosts.


  • Open Access

    Characterizing heterogeneous single-cell dose responses computationally and experimentally using threshold inhibition surfaces and dose-titration assays

    by Patrick C. Kinnunen, Brock A. Humphries, Gary D. Luker, Kathryn E. Luker, Jennifer J. Linderman

    Single cancer cells within a tumor exhibit variable levels of resistance to drugs, ultimately leading to treatment failures. While tumor heterogeneity is recognized as a major obstacle to cancer therapy, standard dose-response measurements for the potency of targeted kinase inhibitors aggregate populations of cells, obscuring intercellular variations in responses. In this work, we develop an analytical and experimental framework to quantify and model dose responses of individual cancer cells to drugs. We first explore the connection between population and single-cell dose responses using a computational model, revealing that multiple heterogeneous populations can yield nearly identical population dose responses. We demonstrate that a single-cell analysis method, which we term a threshold inhibition surface, can differentiate among these populations. To demonstrate the applicability of this method, we develop a dose-titration assay to measure dose responses in single cells. We apply this assay to breast cancer cells responding to phosphatidylinositol-3-kinase inhibition (PI3Ki), using clinically relevant PI3Kis on breast cancer cell lines expressing fluorescent biosensors for kinase activity. We demonstrate that MCF-7 breast cancer cells exhibit heterogeneous dose responses with some cells requiring over ten-fold higher concentrations than the population average to achieve inhibition. Our work reimagines dose-response relationships for cancer drugs in an emerging paradigm of single-cell tumor heterogeneity.


  • Open Access

    Guide RNA structure design enables combinatorial CRISPRa programs for biosynthetic profiling

    by Jason Fontana, David Sparkman-Yager, Ian Faulkner, Ryan Cardiff, Cholpisit Kiattisewee, Aria Walls, Tommy G. Primo, Patrick C. Kinnunen, Hector Garcia Martin, Jesse G. Zalatan, et al.

    Engineering bacterial metabolism to efficiently produce chemicals and materials from multi-step pathways requires optimizing multi-gene expression programs to achieve enzyme balance. CRISPR-Cas transcriptional control systems are emerging as important metabolic engineering tools for programming multi-gene expression regulation. However, poor predictability of guide RNA folding can disrupt enzyme balance through unreliable expression control. We devised a set of computational parameters that can describe guide RNA folding, and we expect them to be broadly applicable across CRISPR-Cas9 systems. Here, we correlate efficacy of modified guide RNAs (scRNAs) for CRISPR activation (CRISPRa) in E. coli with a kinetic parameter describing folding rate into the active structure. This parameter also enables forward design of new scRNAs, with no observed failures in our screen. We use CRISPRa target sequences from this set to design a system of three synthetic promoters that can orthogonally activate and tune expression of chosen outputs over a >35-fold dynamic range. Independent activation tuning allows experimental exploration of a three-dimensional expression design space via a 64-member combinatorial triple-scRNA library. We apply these CRISPRa programs to two biosynthetic pathways, demonstrating production of valuable pteridine and human milk oligosaccharide products in E. coli . Profiling these design spaces indicated expression combinations producing up to 2.3-fold higher titer than that produced by maximal expression. Mapping production can also identify bottlenecks as targets for pathway redesign, improving titer of the oligosaccharide lacto- N -tetraose by 6-fold. Aided by computational scRNA efficacy prediction, the combinatorial CRISPRa strategy enables effective optimization of multi-step metabolic pathways. More broadly, the guide RNA design rules uncovered here may enable the routine design of effective multi-guide programs for a wide range of model- and data-driven applications of CRISPR gene regulation in bacterial hosts.


  • Open Access

    Oscillatory ERK Signaling and Morphology Determine Heterogeneity of Breast Cancer Cell Chemotaxis via MEK-ERK and p38-MAPK Signaling Pathways

    by Kenneth K. Y. Ho, Siddhartha Srivastava, Patrick C. Kinnunen, Krishna Garikipati, Gary D. Luker, Kathryn E. Luker

    Chemotaxis, regulated by oscillatory signals, drives critical processes in cancer metastasis. Crucial chemoattractant molecules in breast cancer, CXCL12 and EGF, drive the activation of ERK and Akt. Regulated by feedback and crosstalk mechanisms, oscillatory signals in ERK and Akt control resultant changes in cell morphology and chemotaxis. While commonly studied at the population scale, metastasis arises from small numbers of cells that successfully disseminate, underscoring the need to analyze processes that cancer cells use to connect oscillatory signaling to chemotaxis at single-cell resolution. Furthermore, little is known about how to successfully target fast-migrating cells to block metastasis. We investigated to what extent oscillatory networks in single cells associate with heterogeneous chemotactic responses and how targeted inhibitors block signaling processes in chemotaxis. We integrated live, single-cell imaging with time-dependent data processing to discover oscillatory signal processes defining heterogeneous chemotactic responses. We identified that short ERK and Akt waves, regulated by MEK-ERK and p38-MAPK signaling pathways, determine the heterogeneous random migration of cancer cells. By comparison, long ERK waves and the morphological changes regulated by MEK-ERK signaling, determine heterogeneous directed motion. This study indicates that treatments against chemotaxis in consider must interrupt oscillatory signaling.